Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD44 | P16070 | 1/20 | 0.38 |
| ▸ | NQO2 | P16083 | 2/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | GAA | P10253 | 4/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | MMP14 | P50281 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5357984 | 0.84 | HTT (0.38) | ALDH1A1GAAMAPTKDM4ELMNA | |
| SCHEMBL5350044 | 0.75 | CD44 (0.35) | CD44NQO2SRCALDH1A1GAA | |
| SCHEMBL5362078 | 0.73 | MAPT (0.41) | NQO2ALDH1A1GAAMAPTKDM4E | |
| SCHEMBL8703414 | 0.71 | THRB (0.41) | CD44NQO2SRCALDH1A1GAA | |
| SCHEMBL5354970 | 0.68 | MAPT (0.41) | NQO2ALDH1A1MAPTKDM4E | |
| SCHEMBL8702819 | 0.67 | ALDH1A1 (0.33) | ALDH1A1GAAMAPTKDM4ELMNA | |
| SCHEMBL19047158 | 0.65 | ALDH1A1 (0.39) | ALDH1A1GAAMAPTKDM4ELMNA | |
| SCHEMBL1577435 | 0.65 | MAPT (0.35) | ALDH1A1GAAMAPTKDM4ELMNA | |
| SCHEMBL11803251 | 0.64 | ACHE (0.38) | CD44ALDH1A1GAAMAPTKDM4E | |
| SCHEMBL6065571 | 0.62 | HSD17B10 (0.46) | CD44ALDH1A1GAAMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7262284-B2 | Method for producing disazo pigments | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2007-08-28 | — | — | US | disclosed |
| CN-1305971-C | Method for producing disazo pigments | CLARIANT GMBH (DE) | 2007-03-21 | — | — | CN | disclosed |
| US-20060167236-A1 | Method for producing disazo pigments | CLARIANT GMBH (DE) | 2006-07-27 | — | — | US | disclosed |
| CN-1662610-A | Method for producing disazo pigments | CLARIANT GMBH (DE) | 2005-08-31 | — | — | CN | disclosed |
| EP-1517962-A1 | METHOD FOR PRODUCING DISAZO PIGMENTS | Clariant GmbH (DE) | 2005-03-30 | — | — | EP | disclosed |
| WO-2004000947-A1 | METHOD FOR PRODUCING DISAZO PIGMENTS | CLARIANT GMBH (DE) | 2003-12-31 | — | — | WO | disclosed |
| EP-0585873-B1 | Method of preparing disazo pigments | CLARIANT GMBH (DE) | 1997-12-29 | — | — | EP | disclosed |
| US-5559216-A | AZO COUPLING | HOECHST AG (DE) | 1996-09-24 | — | — | US | disclosed |
| US-5493011-A | PIGMENTING HIGH MOLECULAR WEIGHT NATURAL OR SYNTHETIC ORGANIC MATERIALS | HOECHST AG (DE) | 1996-02-20 | — | — | US | disclosed |
| EP-0518909-B1 | WATER-INSOLUBLE AZO DYES, THEIR MANUFACTURE AND USE | HOECHST AG (DE) | 1994-05-25 | — | — | EP | disclosed |
| EP-0585873-A1 | Method of preparing disazo pigments | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-03-09 | — | — | EP | disclosed |
| EP-0316649-B1 | WATER INSOLUBLE AZO COLOURING AGENTS, THEIR PREPARATION AND USE | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-07-22 | — | — | EP | disclosed |
| WO-1991013941-A1 | WATER-INSOLUBLE AZO DYES, THEIR MANUFACTURE AND USE | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-09-19 | — | — | WO | disclosed |
| US-5026831-A | Water-insoluble disazo colorants having hetero-bicyclic methylene-active compounds as coupling component | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-06-25 | — | — | US | disclosed |
| EP-0316649-A2 | Water insoluble azo colouring agents, their preparation and use | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-05-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060167236-A1 | Method for producing disazo pigments | TYR, IPO4, CBR3 | CD44 4743/4885NQO2 246/4885SRC 3857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.